All PlansCoverageMedium impact
Continuous Glucose Monitoring
Blue Cross & Blue Shield of Mississippi·MS · Endocrinology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a comprehensive policy update defining coverage criteria for Continuous Glucose Monitoring (CGM) devices including real-time and intermittent systems. The policy provides detailed information about FDA-approved devices, their indications, and clinical uses for diabetes management.
Action Required
Review current CGM billing practices to ensure alignment with updated device classifications and indications. Verify that claims for CGM devices reference FDA-approved systems listed in the policy. Update prior authorization processes if needed to reflect the distinction between real-time CGM (rtCGM) and intermittently scanned CGM (isCGM) devices.